🟢 Painreform is trading 11.85% up today driven by biotech-sector strength

Painreform is trading 11.85% higher at $1.05 during the active September 23, 2026 session; the move appears primarily sector-driven.

• Biotech is up 2.07%, amid optimism around AI drug-discovery collaboration activity and positive clinical developments.
• No verified Painreform-specific announcement dated September 23 was identified.
• Earlier company updates, including GridFeed’s data-center strategy, predated September 23 and do not directly explain the move.